iosBio

iosBio
#Thermostable #Vaccine platform for room temp & above storage.
Oral #vector platform for #vaccines, #biopharmaceuticals.
#zika #virus

[iosBio @iosBioPharma]

We have a new website! As we progress oral vaccines development against infectious diseases e.g. #COVID19 and #flu, our new website showcases our unique #OraPro technology and efforts to transform the future of immunization. Visit our website here: https://t.co/jE73oX15rY

[iosBio @iosBioPharma]

We’re pleased to welcome Dr. Craig Laferrière as our new CDO.

Craig is a highly experienced medical adviser, with more than 25 years’ experience working in #vaccine design, manufacturing and licensing. Read more: https://t.co/oHGWtUonnD

#appointment #vaccines #oralvaccine

[iosBio @iosBioPharma]

#Nipah virus has the potential to be a future pandemic threat. We spoke to Executive Chairman, Wayne Channon, about Nipah and our Nipah oral vaccine candidate.

The full #QandA is available here:

https://t.co/jIO32NboHM

#oralvaccines #ICYMI

[iosBio @iosBioPharma]

Its #worldimmunizationweek! We spoke to our Executive Chairman on the development of our oral #Nipah virus vaccine candidate with funding from @DHSCgovuk's UK #Vaccine Network programme, delivered by @innovateuk. Read our full #QandA here:
https://t.co/GmXjgrUzbi
#alonglifeforall

[iosBio @iosBioPharma]

This World Immunization Week we're supporting @WHO’s campaign to raise awareness of the value of vaccines and immunization. Our mission, like theirs, is to help people be protected from vaccine-preventable diseases.

Find out more: https://t.co/0p02v8pvyx

#alonglifeforall

[iosBio @iosBioPharma]

Excited to announce the appointment of Ben Warriner as our new Chief Financial Officer.

Ben is a highly experienced finance professional with more than a decade of international leadership experience.

Read our full announcement: https://t.co/A9HSCIyHmu

#biotech #appointment

[iosBio @iosBioPharma]

Excited to announce that we have received a grant from the @DHSCgovuk UK #Vaccine Network programme, delivered by @innovateuk to develop an #oralvaccine against #Nipahvirus, using our #OraPro technology.

Read our full announcement: https://t.co/heu4hWQiLC

#immunisation #biotech

[iosBio @iosBioPharma]

Earlier this week, we shared an interview with our Chief Innovation Officer, Jeff Drew. Read the full #QandA here: https://t.co/CW9thoE65R

#OraPro #QandA #oralvaccines #interview

[iosBio @iosBioPharma]

Great to see our recent Fluvid trial results being picked up in Daily Express this weekend, you can read the full article here:

https://t.co/Pr3JSNykzD

#fluvaccine #covidvaccine #coldchain #immunisation

[iosBio @iosBioPharma]

Great to see so many of our peers at this year’s World Vaccine and Immunotherapy Congress 2021. Thanks to @vaccinenation for this important meeting as we continue to navigate the #COVID19 pandemic alongside existing viruses such as #flu.

#oralvaccine #immunization #WVIC

[iosBio @iosBioPharma]

Delighted to be attending the World Vaccine and Immunotherapy Congress 2021 @vaccinenation this week, taking place from 30th November – 2nd December in San Diego.

https://t.co/GWATixmyYa

#immunization #oralvaccine #WVIC

[iosBio @iosBioPharma]

Great to be featured in the @smh, discussing how oral vaccines can revolutionize the fight against COVID-19, overcoming the need for cold chain storage and providing a more targeted immune response.
Read the full article: https://t.co/Ulgr3e4g3i
#COVID19 #OralVaccines

[iosBio @iosBioPharma]

@waynechannon, our CEO, spoke to @MTatalovic at @ResFortnight about iosBio, and our work investigating a potential #Zika #vaccine before utilising our OraPro™ technology to develop an #oralvaccine for #COVID19.
Full article: https://t.co/5tJZd6NxWO

[Research Fortnight @ResFortnight]

How a UK firm put a Covid-19 vaccine in a pill: Wayne Channon, head of iosBio, on starting with Innovate UK money before turning to America. @iosBioPharma @immunitybio @waynechannon

https://t.co/NCNHm3Bpga

[iosBio @iosBioPharma]

How easy is it to take one of our #oralvaccines?
@TVTOKYO_PR visited our #laboratories last week to find out, and to see the innovative science behind our oral vaccines and our incredible team in action!
Watch their visit here: https://t.co/onVxu8MRQ4
#COVID19

[iosBio @iosBioPharma]

We are pleased to note our partner @immunitybio has recieved FDA authorization to expand Phase I testing of its T-cell-based #COVID19vaccine candidate, hAd5, which uses our proprietary OraPro™ thermal stabilization technology for #oraldelivery.

[ImmunityBio, Inc. @ImmunityBio]

@ImmunityBio and @NantKwest receive FDA authorization to expand Phase I testing of a bivalent hAd5 T-cell COVID-19 vaccine. We will enroll another 105 participants in the U.S. trials of our vaccine candidate. #Immunotherapy #CellTherapy #SARSCoV2
https://t.co/LoAMxALWii

[iosBio @iosBioPharma]

Read more about our #oralvaccine technology here: https://t.co/wZ7QdB11G8
#COVIDvaccine #COVID19

[iosBio @iosBioPharma]

“It's certainly conceivable that you can get [a COVID19 vaccine] that would be orally administered and in fact there are some biotech companies right now as we speak that are working on such a variation of the vaccine.” Dr Anthony Fauci on BBC Radio 4 ‘How to Vaccinate the World’

[BBC Radio 4 @BBCRadio4]

To achieve herd immunity 70-85% of the population needs to be vaccinated or have been infected, estimates Dr Fauci, the top US infectious diseases expert.

Full interview: https://t.co/CrvhdLQ4o9

[iosBio @iosBioPharma]

Great to be featured in @Telegraph. As vaccine taskforces and medical experts around the world consider easy to distribute and administer alternatives to injectable vaccines, we are proud to be positioned at the centre of innovation with our #oralvaccine technology #COVID19

[The Telegraph @Telegraph]

Nadhim Zahawi has suggested coronavirus vaccines could eventually be administered in the form of a pill https://t.co/55IAiyRXNS

[iosBio @iosBioPharma]

Our Chairman, @waynechannon, spoke to @MTatalovic at @ResFortnight about our partnership with @immunitybio, and the ongoing trials in South Africa and the US.
The #COVID19 #oralvaccine candidate targets both the mutation prone spike protein and more stable nucleocapsid protein.

[Research Fortnight @ResFortnight]

Covid vaccine pill enters clinical trials: US and South Africa trials test oral vaccine whose capsule technology was developed in UK. @immunitybio @iosBioPharma @innovateuk

https://t.co/TATg6JBKVS

[iosBio @iosBioPharma]

“Probably one of the most vital innovations the world needs right now”, @anandmahindra, Chairman of the @MahindraRise, comments on our OraPro™ technology, which is currently being used to develop oral COVID-19 vaccines.

#oralvaccines #COVID19 #vaccination

[anand mahindra @anandmahindra]

Don’t know if there’s any validity in this report. But would the Nobel Academy please give them a Nobel if they succeed? Probably one of the most vital innovations the world needs right now...